PMID- 20833973 OWN - NLM STAT- MEDLINE DCOM- 20110222 LR - 20220321 IS - 1538-7755 (Electronic) IS - 1055-9965 (Print) IS - 1055-9965 (Linking) VI - 19 IP - 11 DP - 2010 Nov TI - No effect of exercise on insulin-like growth factor-I, insulin, and glucose in young women participating in a 16-week randomized controlled trial. PG - 2987-90 LID - 10.1158/1055-9965.EPI-10-0828 [doi] AB - INTRODUCTION: Insulin-like growth factor I (IGF-I) and IGF binding protein 3 (IGFBP-3) have been associated with increased risk of breast cancer. METHODS: We report our findings on the effects of 16 weeks of aerobic exercise on IGF axis proteins, insulin, glucose, and insulin resistance of 319 young sedentary women. Demographics, health surveys, body composition, dietary intake, and blood samples were collected at baseline and 16 weeks. IGF-I and IGFBP-1, IGFBP-2, and IGFBP-3 were measured by ELISA. RESULTS: Exercise adherence was 88%. The dropout rates for the exercise and control groups were 21.7% and 14.5%, respectively. There was a small significant change from baseline in IGFBP-3 concentrations. IGFBP-3 levels decreased in controls and increased in exercisers. The between-group difference was significant. No other changes were noted. CONCLUSION: Sixteen weeks of exercise had minimum or no effect on IGF proteins of young women. IMPACT: Our study supports findings from previous studies conducted in older populations and raises the question of what type of intervention is needed to change circulating levels of IGF proteins in humans. CI - (c)2010 AACR. FAU - Arikawa, Andrea Y AU - Arikawa AY AD - Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108, USA. aarikawa@umn.edu FAU - Kurzer, Mindy S AU - Kurzer MS FAU - Thomas, William AU - Thomas W FAU - Schmitz, Kathryn H AU - Schmitz KH LA - eng GR - M01 RR000400/RR/NCRR NIH HHS/United States GR - R01 CA131333/CA/NCI NIH HHS/United States GR - U54 CA116849/CA/NCI NIH HHS/United States GR - M01-RR00400/RR/NCRR NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural DEP - 20100910 PL - United States TA - Cancer Epidemiol Biomarkers Prev JT - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology JID - 9200608 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 0 (Insulin-Like Growth Factor Binding Protein 1) RN - 0 (Insulin-Like Growth Factor Binding Protein 2) RN - 0 (Insulin-Like Growth Factor Binding Protein 3) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Adolescent MH - Adult MH - Blood Glucose/*analysis/metabolism MH - Breast Neoplasms/blood/*prevention & control MH - Enzyme-Linked Immunosorbent Assay MH - Exercise/*physiology MH - Female MH - Humans MH - Insulin/*blood MH - Insulin-Like Growth Factor Binding Protein 1/blood MH - Insulin-Like Growth Factor Binding Protein 2/blood MH - Insulin-Like Growth Factor Binding Protein 3/blood MH - Insulin-Like Growth Factor I/*analysis/metabolism MH - Young Adult PMC - PMC2976790 MID - NIHMS234243 EDAT- 2010/09/14 06:00 MHDA- 2011/02/23 06:00 PMCR- 2011/11/01 CRDT- 2010/09/14 06:00 PHST- 2010/09/14 06:00 [entrez] PHST- 2010/09/14 06:00 [pubmed] PHST- 2011/02/23 06:00 [medline] PHST- 2011/11/01 00:00 [pmc-release] AID - 1055-9965.EPI-10-0828 [pii] AID - 10.1158/1055-9965.EPI-10-0828 [doi] PST - ppublish SO - Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2987-90. doi: 10.1158/1055-9965.EPI-10-0828. Epub 2010 Sep 10.